Phase III trial of bucindolol in patients with chronic heart failure selected based on genotype.

Trial Profile

Phase III trial of bucindolol in patients with chronic heart failure selected based on genotype.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 May 2011

At a glance

  • Drugs Bucindolol (Primary) ; Metoprolol succinate
  • Indications Chronic heart failure
  • Focus Pharmacogenomic; Registrational; Therapeutic Use
  • Sponsors ARCA biopharma Inc
  • Most Recent Events

    • 24 Nov 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top